Trials / Completed
CompletedNCT01244763
Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia
A Phase 2, Randomized, Open-Label, Dose Titration, Efficacy and Safety Study of FG-4592 (Roxadustat) in Non-Dialysis Chronic Kidney Disease Patients With Anemia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Kyntra Bio · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to evaluate efficacy and safety of roxadustat in the correction of anemia in participants with non-dialysis chronic kidney disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Roxadustat | Oral capsule |
Timeline
- Start date
- 2010-10-29
- Primary completion
- 2012-06-13
- Completion
- 2012-06-13
- First posted
- 2010-11-19
- Last updated
- 2022-02-10
- Results posted
- 2022-02-10
Locations
38 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT01244763. Inclusion in this directory is not an endorsement.